Clinical trial
Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone…
NCT00201851 · International Breast Cancer Research Foundation, Other · Completed
Key facts
| NCT number | NCT00201851 |
|---|---|
| Title | Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-Positive Breast Cancer |
| Official title | Phase III Randomized Study of Immediate Versus Luteal Phase Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-positive Breast Cancer |
| Lead sponsor | International Breast Cancer Research Foundation, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Procedure |
| Interventions | Tamoxifen, Surgery: Oophorectomy |
| Enrollment | 740 |
| Start date | Jan 1, 2004 |
| Primary completion | Dec 1, 2011 |
| Completion | May 1, 2013 |
| First posted | Sep 20, 2005 |
| Last update posted | Apr 29, 2015 |
| Countries | Morocco, Philippines, Vietnam |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: